Serum Cardiac Markers: A Key to Diagnosing Heart Conditions

Introduction

Serum cardiac markers are substances released into the blood when the heart muscle suffers damage. They are crucial in diagnosing and managing cardiac conditions, particularly acute coronary syndromes (ACS) like myocardial infarction (heart attack).

Types of Serum Cardiac Markers

1. Troponins (Troponin I and Troponin T)

  • Most specific and sensitive markers of myocardial injury.
  • Elevated levels indicate heart muscle damage.
  • Typically rise within 3-4 hours after an acute myocardial infarction (AMI) and remain elevated for up to 10–14 days.

2. Creatine Kinase-MB (CK-MB)

  • Less specific than troponins but useful in detecting early reinfarction.
  • Peaks within 12-24 hours and returns to normal in 2-3 days.

3. Myoglobin

  • First marker to rise (within 1-2 hours), but it lacks specificity.
  • Not used alone for diagnosis, but helpful in early detection.

4. B-type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP)

  • Primarily used to assess heart failure rather than myocardial infarction.
  • Elevated levels correlate with heart failure severity.

Clinical Importance

  • Diagnosis of Myocardial Infarction: Troponins remain the gold-standard biomarkers for heart attack diagnosis.
  • Risk Stratification: Patients with elevated troponins have a higher risk of complications and require urgent intervention.
  • Monitoring Treatment: Serial measurement of cardiac markers helps track the progression and recovery of cardiac injury.

Conclusion

Serum cardiac markers play an essential role in detecting and managing heart-related conditions, particularly myocardial infarction. Among them, troponins are the most reliable indicators. Understanding these markers helps ensure timely diagnosis and treatment, reducing the risk of complications.

Source recommendations

1. American College of Cardiology/American Heart Association Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction

  1. https://pubmed.ncbi.nlm.nih.gov/15289388/
  2. https://professional.heart.org/en/science-news/2021-acc-aha-scai-guideline-for-coronary-artery-revascularization
  3. https://www.sciencedirect.com/science/article/pii/S073510972106157X
  4. https://www.ahajournals.org/doi/10.1161/cir.0b013e3182742cf6
  5. https://www.acc.org/Guidelines

2. European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation

  1. https://pubmed.ncbi.nlm.nih.gov/32860058/
  2. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Acute-Coronary-Syndromes-ACS-Guidelines
  3. https://pubmed.ncbi.nlm.nih.gov/26320110/
  4. https://academic.oup.com/eurheartj/article/42/14/1289/5898842
  5. https://pubmed.ncbi.nlm.nih.gov/21873419/

Our advantages:

patient2376100
Best practices from USA, EU and Japan
Our answers to your questions are based on the clinical recommendations of countries with the most developed healthcare systems in the field of cardiology in the USA, the EU and Japan.
prescription18648039
Always up-to-date information
On a daily basis, we monitor for you all new scientific research publications in leading scientific journals on medical issues of interest to you.
We monitor all innovations and changes in the field of cardiac disease treatment on a daily basis.
fvfflf7q
Get second opinion
Here you can learn everything that even your doctor may not know about cardiology (if he does not speak English and he does not read 117 leading medical journals on cardiology every month).
1xr4duup
The most comprehensive and up-to-date collection of free cardiology materials
Our website contains the most comprehensive and up-to-date collection of free cardiology materials in your country.
Every 3-5 years, half of the scientific approaches to treatment in the field of cardiology are reviewed as a result of specialized scientific discoveries. With us, you don't have to wait these years to learn about the best ways to treat you and your loved ones.
arrow
Please register in order to receive information regarding possible complications and new approaches to treatment of cardiovascular diseases via email in our Newsletters.
arrow